Quantcast

Latest Oncology Stories

2014-07-14 23:08:32

The Mesothelioma Victims Center is incredibly passionate about making certain all diagnosed victims of mesothelioma get the best possible compensation, because as they would like to explain with one call to 866-714-6466, mesothelioma cancer treatment is expensive. This week the group has found an article on the subject and want to pass it along to victims and their family, and add that the skyrocketing treatment costs is why they offer instant access to the nation's most skilled...

2014-07-14 23:00:32

LIVESTRONG and thinksport Produce Chemical Conscious Sunscreens Without Toxins Austin, Texas (PRWEB) July 14, 2014 Protect Against the Most Common Form of Cancer in the U.S. During UV Safety Month LIVESTRONG and thinksport Produce Chemical Conscious Sunscreens Without Toxins Nearly half of all cancers in the U.S. are skin cancers, with 3.5 million cases diagnosed each year. During July, UV safety month, the LIVESTRONG Foundation asks Americans to make UV safety a priority and avoid...

2014-07-14 12:55:18

The Lancet Failure to get the best treatment and variations in the quality of care are the most likely reasons why survival for blood cancer patients still varies widely between regions within Europe, according to the largest population-based study of survival in European adults to date, published in The Lancet Oncology. "The good news is that 5-year survival for most cancers of the blood has increased over the past 11 years, most likely reflecting the approval of new targeted drugs in...

2014-07-14 12:24:41

Surveyed Payers Formulary Placement of Novel Agents is Likely to be Influenced by Breakthrough Therapy Designation, According to Findings from Decision Resources Group BURLINGTON, Mass., July 14, 2014 /PRNewswire/ -- Decision Resources Group finds that breakthrough therapy designation is likely to positively influence perceptions of emerging drugs for both oncologists and payers. Results of a survey of 100 oncologists (50 medical oncologists and 50 hematological oncologists) and 30 medical...

2014-07-14 08:26:52

Company Commemorates its Transformative Acquisition of EGEN, Inc. and the Initiation of the Phase III Pivotal OPTIMA Study in Primary Liver Cancer LAWRENCEVILLE, N.J., July 14, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, announced today that the Company will ring the NASDAQ Stock Market closing bell on Wednesday, July 16, 2014 in Times Square, New York, NY. President and CEO Michael H. Tardugno and members of the Celsion and...

2014-07-13 23:01:48

The Firm is evaluating power morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine cancers due to laparoscopic hysterectomies and fibroid removals. New York, New York (PRWEB) July 13, 2014 A Massachusetts couple who have done so much to bring attention to the cancer risks associated with power morcellators (http://www.gynecaremorcellatorlawsuit.com/) finally had a chance to tell their story to federal regulators, as they presented poignant testimony on...

2014-07-11 23:08:08

The Mesothelioma Victims Center is calling for a new national focus on a rare form of cancer called mesothelioma, because they fear most people do not know what it is, nor do most people understand this malignant illness shows up decades after exposure to asbestos. Diagnosed victims of mesothelioma, or their family members, are urged to contact the Mesothelioma Victims Center anytime at 866-714-6466 for their unsurpassed free services focused on the best possible mesothelioma compensation,...

2014-07-11 23:05:26

Scientists say slight inherited differences in the genes may help predict how mesothelioma patients will respond to chemotherapy. Raleigh, NC (PRWEB) July 11, 2014 Cancer researchers in Slovenia say genetic variations called polymorphisms appear to have a significant impact on how patients respond to treatment with pemetrexed (Alimta), the most popular chemotherapy drug for mesothelioma. Surviving Mesothelioma has the full story. Click here to read the new post now. Researchers at the...

2014-07-11 23:01:48

The Firm is evaluating power morcellator lawsuits on behalf of women who experienced an upstaging of uterine sarcomas or other cancers, allegedly due to uterine morcellation. New York, NY (PRWEB) July 11, 2014 As part of its morcellator lawsuit (http://www.gynecaremorcellatorlawsuit.com/) investigation, Bernstein Liebhard LLP has been closely monitoring the ongoing meeting of the U.S. Food & Drug Administration’s (FDA) Obstetrics and Gynecology Devices Panel, which has been...

2014-07-11 10:56:11

Massachusetts General Hospital Circulating tumor cells captured with a microchip-based device developed at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine and the MGH Cancer Center can be cultured to establish cell lines for genetic analysis and drug testing. In the July 11 issue of Science, an MGH research team reports that the cultured cells accurately reflect a tumor's genetic mutation over time and changing susceptibility to therapeutic drugs. "We now...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related